We are developing solutions for aging society including AlzWIN, an FDA-registered AI dementia screener using 1-minute voice data. The AI solution uses semantic and lexical speech analysis for early, accurate detection and prevention of cognitive decline, outperforming traditional acoustic-based tools and enabling sensitive screening.